G1 Therapeutics to Participate in the Cowen 43rd Annual

G1 Therapeutics to Participate in the Cowen 43rd Annual

RESEARCH TRIANGLE PARK, N.C., Feb. 28, 2023 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today......

menu
menu